CD8A and cancer: By leveraging MBTA vaccine treatment with tumor cell co-culture and irradiation, we have previously established the ability to induce a pro-inflammatory innate response that transitions into a CD8+ cytotoxic T lymphocyte response in other murine cancer models [23].